SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053535
Filing Date
2020-11-12
Accepted
2020-11-12 16:01:03
Documents
64
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alrn-10q_20200930.htm 10-Q 2363153
2 EX-31.1 alrn-ex311_8.htm EX-31.1 16320
3 EX-31.2 alrn-ex312_7.htm EX-31.2 16196
4 EX-32.1 alrn-ex321_9.htm EX-32.1 7924
5 EX-32.2 alrn-ex322_6.htm EX-32.2 7037
  Complete submission text file 0001564590-20-053535.txt   7257446

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alrn-20200930.xml EX-101.INS 1402402
7 XBRL TAXONOMY EXTENSION SCHEMA alrn-20200930.xsd EX-101.SCH 46089
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alrn-20200930_cal.xml EX-101.CAL 38798
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alrn-20200930_def.xml EX-101.DEF 171970
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alrn-20200930_lab.xml EX-101.LAB 397678
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alrn-20200930_pre.xml EX-101.PRE 317886
Mailing Address 490 ARSENAL WAY WATERTOWN MA 02472
Business Address 490 ARSENAL WAY WATERTOWN MA 02472 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38130 | Film No.: 201306477
SIC: 2834 Pharmaceutical Preparations